The Uromigos

Episode 130: Larry Einhorn - The Uromigos Legends in GU Cancer series 06.09.2021 33:37 ↓

Larry Einhorn describes the spectacular advances in testis cancer. 

Episode 129: Phil Kantoff - The Uromigos Legends in GU Cancer series 02.09.2021 31:15 ↓

Phil discusses his career progression and prostate cancer. 

Episode 128: APCCC - PSA relapse post prostatectomy 31.08.2021 26:12 ↓

Neha Vapiwala discusses investigations and treatment for these patients. 

Episode 127: APCCC - Adjuvant radiotherapy post prostatectomy 31.08.2021 28:02 ↓

Alberto Bossi discusses the role of adjuvant therapy. 

Episode 126: APCCC - germ line testing and molecular testing in prostate cancer 31.08.2021 21:50 ↓

Ros Eeles gives a clinically focused overview of this topic. 

Episode 125: The Uromigos Paper of the Month - MRI screening for prostate cancer 27.08.2021 28:10 ↓

Martin Ekland discusses his NEJM and Lancet Oncology papers. 

Episode 124: Dean Bajorin - The Uromigos Legends in GU Cancer series 23.08.2021 33:29 ↓

Dean Bajorin discusses developments in bladder and collaboration in testis cancer. 

Episode 123: Maha Hussain - The Uromigos Legends in GU Cancer series 20.08.2021 30:17 ↓

Maha discusses her career in GU cancer with a focus on prostate cancer. 

Episode 122: Nick Vogelzang - The Uromigos Legends in GU Cancer series 16.08.2021 32:22 ↓

Nick discusses his career and describes treatment advances in RCC. 

Episode 121: Conflicts of Interest with the podcasts 04.08.2021 16:48 ↓

Tom, Brian and Chris discuss developments for Uromigos podcasts and growth for the future. 

Episode 119: EAU - Surgery in urothelial cancer 23.07.2021 24:20 ↓

Ashish Kamat walks through ongoing issues at EAU.

Episode 118: Prostate cancer highlights at EAU 20.07.2021 20:37 ↓

Peter Albers discusses three timely prostate cancer topics from the recent EAU meeting.

Episode 117: PD1/VEGF adverse event management in renal cancer 20.07.2021 27:29 ↓

Betsy Plimack discusses the tricks of the trade. 

Episode 116: Renal cancer surgery controversies at EAU 14.07.2021 22:51 ↓

Grant Stewart gives his opinion on timely RCC surgical topics surrounding the European Association of Urology meeting 

Episode 112: Genomic classifier of high risk African American men with prostate cancer identifying a high-risk population 05.07.2021 20:52 ↓

Kosj Yamoah (Moffitt Cancer Center) describes the work he presented at ASCO 2021. 

Episode 115: Triplet therapy for 1st line metastatic prostate cancer 01.07.2021 23:20 ↓

Eric Small is quizzed about this topic. Tom gets confused between York and Leeds. 

Episode 114: Radionucleotides in prostate cancer 18.06.2021 18:56 ↓

Chris Sweeney and Silke Gillessen give their opinion of recent data. 

Episode 113: ASCO 2021 Enazlutamide +/- Radium-223 18.06.2021 11:03 ↓

Silke Gillessen gives a safety update from this EORTC study focusing on fractures. 

Episode 111: The randomised phase 3 CANTATA in metastatic renal cancer 08.06.2021 29:03 ↓

Nizar Tannir describes the results of this trial with a novel glutaminase inhibitor. 

Episode 110: PEACE1 - Triplet therapy in prostate cancer 08.06.2021 27:51 ↓

Karim Fizazi describes the results of this randomised, potentially practice-changing trial. 

Episode 109: Adjuvant pembrolizumab in renal cancer 07.06.2021 30:45 ↓

Toni Choueiri describes the KN564 study in detail.

Episode 108: Peter O'Donnell gives five year follow-up data on front line pembrolizumab in urothelial cancer 07.06.2021 24:09 ↓

Tom and Peter continue to see things differently - has the data changed things? 

Episode 107: ASCO 2021: Neoadjuvant chemo/nivolumab as bladder sparing 07.06.2021 16:48 ↓

Matt Galsky describes his Phase 2 study and gives a vision of the future.

Episode 106: Summary of the three bladder sparing neoadjuvant trials at ASCO 2021 07.06.2021 26:01 ↓

Andrea Necchi gives a summary of the three abstracts. 

Episode 105: A Phase 2 study of novel immune combinations (ICOS) in bladder cancer 07.06.2021 19:38 ↓

Arjun Balar discusses this and his neoadjuvant chemo/immune/RT trial.